As most authorized vaccines target the production of neutralizing antibodies against the S protein to prevent infection with the SARS-CoV-2 virus, multivalent or updated vaccines have been suggested with the introduction of new variants including those of the Omicron family [12,13,14,15]. This evidence concerns the gene PROS1 and infection.